title: Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
abstract: Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may contribute to the disease pathophysiology by increasing both amyloid-beta (Abeta) production and phosphorylated tau (P-tau) accumulation. Here, we evaluated the relationship between the cerebrospinal fluid (CSF) concentrations of homocysteine (Hcys), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), and 5-methyltetrahydrofolate (5-MTHF), and the markers for AD pathology, Abeta(1-42) and P-tau181, in 98 cognitively healthy subjects aged 16-81 years and 54 AD patients. In multivariate regression tests including age, gender, creatinine, and presence of the apolipoprotein E epsilon4 allele, P-tau181 was associated with SAH (beta = 0.490; p < 0.001), 5-MTHF (beta = -0.273; p = 0.010) levels, and SAM/SAH ratio (beta = -0.319; p = 0.013) in controls, and with SAH (beta = 0.529; p = 0.001) in AD patients. The levels of Abeta(1-42) were not associated with the CSF concentrations of Hcys, SAM, SAH, or 5-MTHF neither in the AD nor in the control group. The results suggest that alteration of the homocysteine metabolism is related to increased accumulation of phosphorylated tau and may contribute to the neurofibrillary pathology in normal aging and in AD.
authors: Department of Psychiatry, University of Bonn, 53105 Bonn, Germany. Julius.Popp@ukb.uni-bonn.de
authors: Julius
authors: J
authors: Popp
authors: Piotr
authors: P
authors: Lewczuk
authors: Michael
authors: M
authors: Linnebank
authors: Gabriela
authors: G
authors: Cvetanovska
authors: Yvo
authors: Y
authors: Smulders
authors: Heike
authors: H
authors: Kölsch
authors: Ingo
authors: I
authors: Frommann
authors: Johannes
authors: J
authors: Kornhuber
authors: Wolfgang
authors: W
authors: Maier
authors: Frank
authors: F
authors: Jessen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000235:genetics / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid* / Q000378:metabolism; D001057:Apolipoproteins E / Q000134:cerebrospinal fluid / Q000235:genetics / Q000378:metabolism; D015415:Biomarkers / Q000134:cerebrospinal fluid; D016022:Case-Control Studies; D005260:Female; D005838:Genotype; D006710:Homocysteine / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009483:Neuropsychological Tests; D010446:Peptide Fragments / Q000134:cerebrospinal fluid* / Q000378:metabolism; D012436:S-Adenosylmethionine / Q000134:cerebrospinal fluid / Q000235:genetics; D013763:Tetrahydrofolates / Q000134:cerebrospinal fluid / Q000235:genetics; D055815:Young Adult; D016875:tau Proteins / Q000134:cerebrospinal fluid* / Q000235:genetics / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D015415:Biomarkers; D010446:Peptide Fragments; D013763:Tetrahydrofolates; C075222:amyloid beta-protein (1-42); D016875:tau Proteins; D006710:Homocysteine; D012436:S-Adenosylmethionine; C005984:5-methyltetrahydrofolate